Awardee OrganizationUNIVERSIDAD CENTRAL DEL CARIBE
Description
Abstract Text
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The goal of this component is to establish a core laboratory with the needed human and physical resources to support research studies in the areas of HIV/AIDS and substances of abuse. For the next five years, specialized facilities will be made available to researchers for scientific studies in fields of immunology, drugs of abuse, HIV/AIDS and related infectious diseases. An in vitro system will be developed to test for the effect of addiction-related drugs and their interaction on HIV replication and the immune response under controlled laboratory conditions. The core lab will provide researchers with assays for nucleic acids detection, virus genotyping, flow-cytometric phenotyping, lymphocyte proliferation, cytotoxic and non-cytotoxic activity, cytokine and chemokine determinations, and drugs of abuse quantification. Consultants and mentors will continue to be available to users for the effective development of their projects and foster collaboration with external researchers. Moreover, support is requested to improve specimen repository, laboratory information system, electronic communication with Data Core, and compliance with HIPAA and IRB regulations. Furthermore, an institutionalizing effort of RCMI-supported infrastructure is described.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS/HIV problemAreaBiological AssayClinical Laboratory Information SystemsCollaborationsCommunicable DiseasesCommunicationComputer Retrieval of Information on Scientific Projects DatabaseConditionDataDevelopmentElectronicsFosteringFundingGenotypeGoalsGrantHIVHealth Insurance Portability and Accountability ActHumanImmune responseImmunologyIn VitroInstitutionLaboratoriesMentorsPharmaceutical PreparationsPhenotypeRegulationResearchResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResourcesSourceSpecimenSubstance abuse problemSubstance of AbuseSupport of ResearchSystemTestingUnited States National Institutes of HealthVirusaddictionchemokinecytokinecytotoxicdrug of abuseimprovedlymphocyte proliferationnucleic acid detectionrepositoryresearch study
No Sub Projects information available for 5G12RR003035-22 6664
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5G12RR003035-22 6664
Patents
No Patents information available for 5G12RR003035-22 6664
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5G12RR003035-22 6664
Clinical Studies
No Clinical Studies information available for 5G12RR003035-22 6664
News and More
Related News Releases
No news release information available for 5G12RR003035-22 6664
History
No Historical information available for 5G12RR003035-22 6664
Similar Projects
No Similar Projects information available for 5G12RR003035-22 6664